Now I have all the evidence needed. Let me synthesize the review.

## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that self-generates lesion proposals without requiring expensive external annotations. Two modules are introduced: (1) GALP, which derives grade-conditioned evidence maps (GEMs) from stage-wise auxiliary classifiers and selects top-K high-evidence regions as lesion proposals, and (2) LGRF, a cross-view fusion module that uses a gated mixture-of-experts to selectively fuse proposal-guided features across views. Experiments on two multi-view DR datasets (MFIDDR, DRTiD) show the w/o-lesion variant achieves competitive accuracy (83.9%, 76.0%) that surpasses all end-to-end baselines and approaches externally-informed methods, while the with-lesion variant reaches state-of-the-art.

## Strengths

- **Well-motivated problem and clean framing.** The paper clearly identifies the real tension between end-to-end multi-view grading (which misses micro-lesions due to spatial compression) and externally-informed methods (which require costly annotations), and proposes a sensible middle ground: self-generating lesion proposals within the grading pipeline. The "Switch = On/Off" framing in Figure 1 effectively communicates the trade-off.

- **The GALP mechanism is a genuine technical contribution.** Deriving lesion proposals from grade-conditioned evidence maps (GEMs) computed from auxiliary classifiers is a non-trivial way to obtain spatially localized grade-relevant signals without pixel-level supervision. The Top-K selection on CAM-derived maps is a reasonable design that distinguishes this work from prior methods requiring separate lesion segmenters or clinician annotations. This mechanism is the paper's core intellectual contribution.

- **Competitive empirical results on two benchmarks.** On MFIDDR, the w/o-lesion variant (83.9% Acc) surpasses all end-to-end baselines (best: ETMC at 81.5%) by a clear 2.4% margin and approaches the best externally-informed methods (WGLIN: 84.2%, SMVDR-M: 84.0%). On DRTiD, it achieves 76.0% Acc vs. 75.6% for CrossFIT. These results demonstrate the approach is empirically viable.

- **Ablation study confirms component contributions.** Table 4 shows that removing GALP (82.7%), removing LGRF (82.3%), or removing the expert pool (82.6%) all degrade accuracy relative to the full w/o-lesion model (83.9%), providing basic support for each architectural component.

## Weaknesses

### Fatal
None.

### Major

- **No statistical reliability for central claims.** No confidence intervals, standard deviations, or significance tests are reported for any result on either dataset. This is critical because several key comparisons involve narrow margins: the w/o-lesion variant (83.9%) trails SMVDR-M (84.0%) by 0.1% and WGLIN (84.2%) by 0.3% on MFIDDR, and leads CrossFIT (75.6%) by only 0.4% on DRTiD. The paper's headline claim of "closing the gap" rests on differences that could easily fall within run-to-run variation from a single train/test split. Without variance estimates, readers cannot assess whether the empirical contribution is substantive or reflects noise. The hyperparameter analysis (Figure 3) also reports single values per setting with no indication of variation.

- **Interpretability claim is unsubstantiated.** The paper claims "superior robustness and interpretability" as a contribution (Section 1, Contribution 2) but provides zero supporting evidence. No visualization of GEMs, no examples of selected lesion proposals, no comparison of what regions GALP attends to versus clinical lesion annotations (which are available for MFIDDR), and no interpretability evaluation (e.g., what fraction of proposals overlap actual lesions). For a paper whose mechanism explicitly produces spatial proposals and claims interpretability as a benefit, this is a significant evidential gap that should either be filled or the claim removed.

- **GALP mechanism has an unaddressed failure mode.** Equation (3) computes GEMs using the class weights from the *predicted* grade of the auxiliary classifier, not the ground-truth grade. If the auxiliary classifier makes an incorrect prediction, the CAM highlights regions discriminative for the *wrong* class, directing the fusion module toward evidence for an incorrect grade. The paper provides no analysis of auxiliary classifier accuracy at any stage and no discussion of how this failure mode is mitigated. Since the auxiliary classifiers are shallow heads attached to intermediate features (which may not yet be fully discriminative), their error rates could be non-trivial.

### Minor

- **The "Ours (with lesion)" SOTA claim risks conflation with the core contribution.** The with-lesion variant (84.6%) uses ground-truth lesion masks via SPADE fusion — it is an externally-informed method, not a demonstration of self-generated proposals. The paper is transparent about this setup, but presenting this variant as "establishing new SOTA" in the narrative alongside the w/o-lesion contribution risks conflating two different capabilities.

- **Key training hyperparameters are not reported.** The paper omits standard details: learning rate, optimizer, batch size, number of epochs, learning rate schedule, weight decay, and data augmentation strategy. The implementation details section only specifies backbone, pretraining, patch sizes, loss weights, retention ratio, and expert counts. This makes reproduction difficult and raises questions about whether comparisons with baselines reflect equally tuned settings.

- **Several architectural components are underspecified.** The auxiliary head CNN_{s_n} (number of layers, kernel sizes), the Transformer experts Tr_{s_n,k_2}^j (layers, heads, hidden dimension), the Router dimensionality, and the number of heads in MHACVA are not stated, making the method description less complete than would be desirable.

- **The cyclic adjacency choice is not justified.** The paper states that cross-view fusion operates between adjacent (cyclic) views (i pairs with i+1 mod N) for N=4 views, but provides no rationale for why this restricted connectivity is chosen over all-pairs fusion, which could capture more cross-view correspondences.

- **No computational cost analysis.** The method uses an MoE with 6 Transformer experts plus multiple auxiliary classifiers at each of 4 stages and 4 views, but no inference time, parameter count, or FLOPs are reported. This matters for the paper's claim of "practical potential for clinical deployment."

### Trivial
None.

## Nice-to-Haves
- The "w/o GALP" ablation (which uses all tokens for LGRF) conflates the removal of proposal selection with a change in LGRF's input; a cleaner ablation would independently vary proposal selection (GALP) from fusion mechanism (LGRF).
- Grade-wise performance on DRTiD could be expanded beyond AUC (e.g., F1, precision, recall) for fuller characterization, though the paper follows the established protocol.

## Removed Points
These points are flagged to be removed; treat them with caution:
1. "No analysis of grade-wise performance on DRTiD" — REMOVED because Table 3 does report AUC per grade for DRTiD. The paper explicitly follows the CrossFIT protocol which standardizes Acc + AUC per grade for this dataset. Demanding additional metrics beyond the established protocol is scope creep.
2. "DRTiD evaluation missing specificity and Kappa" — REMOVED because the paper follows the established evaluation protocol for this benchmark. Criticizing adherence to a standard protocol is not reasonable.

## Novel Insights
None beyond the paper's own contributions. The reviewer observations about the need for statistical reliability and interpretability evidence are standard expectations for empirical papers rather than novel insights.

## Suggestions
1. **(Highest priority)** Add run-to-run variance estimates (at least 3 random seeds) for all main results and ablations. This single addition would transform the empirical grounding of the paper.
2. Include a qualitative figure showing GEMs and Top-K proposals for example eyes, preferably alongside ground-truth lesion annotations (available for MFIDDR), to substantiate the interpretability claim.
3. Report auxiliary classifier accuracy at each stage to address the predicted-grade failure mode in GALP.
4. Report standard training hyperparameters (learning rate, optimizer, batch size, epochs, schedule, augmentation) in a supplements table.

## Score and Decision

The paper tackles a well-motivated problem and the GALP mechanism for self-generating lesion proposals is a genuine contribution. The w/o-lesion results are competitive, surpassing all end-to-end baselines and approaching externally-informed methods. However, the paper has three significant weaknesses that prevent it from being fully convincing in its current form: (1) the complete absence of statistical reliability measures for narrow-margin comparisons, (2) an unsubstantiated interpretability claim despite framing it as a contribution, and (3) an unaddressed failure mode in the GALP mechanism's reliance on potentially incorrect auxiliary classifier predictions. These issues are addressable in revision but meaningfully weaken the evidence base as presented.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>